Results 241 to 250 of about 282,663 (297)

Ten years of experience with ruxolitinib since approval for polycythemia vera: A review of clinical efficacy and safety. [PDF]

Cancer
Masarova L, Mascarenhas J, Rampal R, Hu W, Livingston RA, Pemmaraju N.   +5 more
europepmc   +1 more source

Evidence of jak2 val617phe positive essential thrombocythemia with splanchnic thrombosis during estroprogestinic treatment [PDF]

, 2008
Colagrande, M, Di Ianni,M, Lapecorella, M, Lucchesi,A, Mariani, G., NAPOLITANO, Mariasanta, Tabilio, A   +6 more
core  

The assessment of health-related quality of life in patients with polycythemia vera. [PDF]

Medicine (Baltimore)
Doğan EE, Keklik Karadağ F, Aydin D, Demirel N, Sağlam S, Davulcu EA, Turan Erkek E, Eren R, Akad Soyer N, Şahin F, Saydam G.   +10 more
europepmc   +1 more source

Event-free survival in early polycythemia vera patients correlates with molecular response to ropeginterferon alfa-2b or hydroxyurea/best available therapy (PROUD-PV/CONTINUATION-PV). [PDF]

Hemasphere
Kiladjian JJ, Klade C, Georgiev P, Krochmalczyk D, Gercheva-Kyuchukova L, Egyed M, Dulicek P, Illes A, Pylypenko H, Sivcheva L, Mayer J, Yablokova V, Krejcy K, Empson V, Hasselbalch HC, Kralovics R, Gisslinger H, PROUD‐PV Study Group.   +17 more
europepmc   +1 more source

Treatment of the blood cancer polycythemia vera with ruxolitinib in the MAJIC-PV study: a plain language summary. [PDF]

Future Oncol
Harrison CN, Fox S, Boucher R, McMullin MF, Mead AJ.   +4 more
europepmc   +1 more source

Polycythemia vera and noncirrhotic portal hypertension diagnosed during pregnancy. [PDF]

CMAJ
Frank C, Amily N, Kelly E, Kimpton M, Villeneuve P, O'Meara P.   +5 more
europepmc   +1 more source

Advancements and Future Directions in Polycythemia Vera Research: A Bibliometric Analysis. [PDF]

Cureus
Xavier B.
europepmc   +1 more source

Long-term safety and efficacy of ropeginterferon alfa-2b in Japanese patients with polycythemia vera. [PDF]

Int J Hematol
Kirito K, Sugimoto Y, Gotoh A, Takenaka K, Ichii M, Inano T, Shirane S, Ito M, Zagrijtschuk O, Qin A, Kawase H, Sato T, Komatsu N, Shimoda K.   +13 more
europepmc   +1 more source

Neutrophil-to-lymphocyte ratio as a prognostic indicator of mortality in Polycythemia Vera: insights from a prospective cohort analysis. [PDF]

Blood Cancer J
Barbui T, Carobbio A, Ghirardi A, Fenili F, Finazzi MC, Castelli M, Vannucchi AM, Guglielmelli P, Rambaldi A, Gangat N, Tefferi A.   +10 more
europepmc   +1 more source